Skip to content

Merck & Co. MRK Change in Inventories

Change in Inventories at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$14M-108%
Pfizer logo
PfizerPFE
-$140.25M-166%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$431M+195%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$26.6M-117%
Phibro Animal Health logo
Phibro Animal HealthPAHC
$19.33M+40.8%
Cytokinetics logo
CytokineticsCYTK

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$317.37B+61.7%
Enterprise value$361.07B+60.4%
P/E35.5×+23.6×
P/S4.8×+1.7×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp
FCF margin21.5%-5.2pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Merck & Co.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s change in inventories?
Merck & Co. (MRK) reported change in inventories of $295M in Q4 2025.
How has Merck & Co.'s change in inventories changed year-over-year?
Merck & Co.'s change in inventories increased by 41.3% year-over-year, from $208.75M to $295M.
What is the long-term trend for Merck & Co.'s change in inventories?
Over 4 years (2021 to 2025), Merck & Co.'s change in inventories has grown at a 15.0% compound annual growth rate (CAGR), from $674M to $1.18B.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.